ASML vs INLX

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

The company exhibits severe financial weakness, highlighted by a Piotroski F-Score of 2/9, placing it firmly in the 'Weak' health category. Despite a strong gross margin of 66.05%, the business is struggling with stagnant revenue growth (1.00% YoY) and negative profitability (ROE -17.01%). The technical trend is completely bearish (0/100), and the stock has lost over 53% of its value in the last year. With a Forward P/E of 116.67 and no meaningful growth catalysts, the current valuation is difficult to justify.